Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.
about
Risk factors in coronary atherosclerosis athero-inflammation: the meeting pointLack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteriesInterference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?Genomic approach for analysis of surface proteins in Chlamydia pneumoniaeC-reactive protein as a predictor of improvement and readmission in heart failure.Chlamydia pneumoniae and atherosclerosis.Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.Is cardiovascular disease preventable by vaccination?Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart diseaseChlamydia pneumoniae and coronary heart disease.The anti-inflammatory effects of macrolides.Pathogenic mechanisms in unstable anginaManagement of unstable angina based on considerations of aetiologyAntimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trialLocal immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfectionRecent advances. General medicine.Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease.Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages.Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesThe unfolding story of the chaperonins.Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells.Antibiotics in the prevention and treatment of coronary heart disease.Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective.Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease.Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCRAtherosclerosis: an infectious disease?Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in miceCell wall-deficient bacteria as a cause of infections: a review of the clinical significance.Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.Microorganisms in the aetiology of atherosclerosis.Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease.Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.Immunomodulation by macrolide antibiotics.Current approaches to therapy for vascular injury.Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trialMicrobes, inflammation and atherosclerosis: will old pathology lessons guide new therapies?Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?The role of risk factors in the development of atherosclerosis.
P2860
Q24793107-AD422E93-0B9D-460B-B919-CC805DD3CE25Q24802081-2330B1A9-56A6-4C37-9C25-4A96AFB08AC8Q30327329-C1F5D3A1-FCA6-449F-B37D-49229CA200C4Q31032708-E25C45D9-4C24-4ACA-8C84-6936264F4895Q33147741-E2F2B003-10CF-4C36-8550-41A95BDEDCBDQ33534714-D3B20423-4BA6-4A85-80E4-8B6A416FC361Q33538129-1A42D72B-6FEE-41CB-908A-D29722A19734Q33588103-4B347379-EB8E-4F4F-9887-11186B54900AQ33603398-C20B2196-D866-4439-AD4E-98D0DEF60DB9Q33646625-52FA515A-A879-4B56-A1D7-5CF705B99F76Q33659387-43386F2C-3C25-4099-B624-02AF9CA2F775Q33714051-0F22C5E3-4681-41CA-BA25-341D7828CC24Q33723960-A46CA329-8A20-425D-AC31-6490691F7AD8Q33723966-573D8800-B3C5-4133-A90F-E4FDF1E31E53Q33726287-6CB49F58-9EC0-4806-A976-221E603F64C6Q33752851-29FFFCB2-7F8D-4E92-8583-3E3440C30DB2Q33767275-44D36F63-3068-44B6-B050-979CA699437AQ33791941-3F338C01-EB68-4C3B-A60A-3C00CAB183E7Q33821315-8B3AD7E9-4358-44B4-BB7C-174A7F72FFF9Q33842925-F154878E-6B63-4858-A61D-C7BE3802607CQ33905858-6E298094-57FC-43FE-ADA2-A8F0E26A0651Q33923440-54D4F8B8-5226-4FD3-A8E4-33AD5FC739A3Q33935030-F5EECA69-C3E2-4494-BBAC-FA5AC58DF8D1Q33935098-B0BE0B49-99C2-40A2-A810-F641AEA8A2B2Q33935103-D6D8172F-C0D3-4181-846A-C807F8705C27Q33935109-B5CE755E-0371-4E38-A6CE-00D4DA592972Q33970537-80B1F693-CA0F-4265-9629-D2DBD547C120Q33972834-D3FA890F-F072-4CF5-BDC5-9F977B4E0DCEQ33979917-74A42B81-769E-41D3-A332-A416B64FBD6AQ33984369-53796A5D-BD53-4646-87D9-6ECCAF7269E4Q33987842-B0160468-7CDE-4BE3-955B-64AC6450F814Q34065709-79958EE2-8FB4-4EBC-AB32-802946CCE195Q34097321-5224A5AA-7AF9-42E3-ADA9-DBC647DEB35CQ34125106-F7ABF2F2-FA1E-47DE-A95D-FA650A1FC424Q34172101-BCB8FD1A-B75F-4CEE-A943-B19441D00181Q34241012-388843B3-8951-404C-A1E6-023F511752FEQ34248742-43A305A0-15EE-460A-8E32-8EE0F0204E6AQ34286610-1DAC0D4A-0FE2-4563-9859-098E1594048BQ34316462-B282A195-5320-4682-A7C2-173EB2365A68Q34447107-E9DB9243-8D18-4FA5-8562-F29ED7F0C8F9
P2860
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Randomised trial of roxithromy ...... ilot Study. ROXIS Study Group.
@en
Randomised trial of roxithromy ...... ilot Study. ROXIS Study Group.
@nl
type
label
Randomised trial of roxithromy ...... ilot Study. ROXIS Study Group.
@en
Randomised trial of roxithromy ...... ilot Study. ROXIS Study Group.
@nl
prefLabel
Randomised trial of roxithromy ...... ilot Study. ROXIS Study Group.
@en
Randomised trial of roxithromy ...... ilot Study. ROXIS Study Group.
@nl
P2093
P1433
P1476
Randomised trial of roxithromy ...... ilot Study. ROXIS Study Group.
@en
P2093
P304
P356
10.1016/S0140-6736(97)07201-2
P407
P577
1997-08-01T00:00:00Z